Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary cutaneous lymphoplasmacytic lymphoma.

R M Martí, T Estrach, J Palou

    Journal of the American Academy of Dermatology
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Refractory Dermatomyositis Treated With Anifrolumab: Clinical Response and Dynamics of Type-I Interferon Signature.

    Actas dermo-sifiliograficas·2026
    Same author

    RF-Biological Treatments in Familial Benign Pemphigus or Hailey-Hailey Disease.

    Actas dermo-sifiliograficas·2025
    Same author

    RF-New Treatments in Dermatomyositis: Present and Future.

    Actas dermo-sifiliograficas·2025
    Same author

    Clinical, Histopathological, and Therapeutic Features in Lupus Erythematosus Tumidus: A Retrospective Study.

    Actas dermo-sifiliograficas·2025
    Same author

    Clinical, Histopathological, and Therapeutic Features in Lupus Erythematosus Tumidus: A Retrospective Study.

    Actas dermo-sifiliograficas·2025
    Same author

    [Translated article] RF- Relationship Between Porokeratosis and Skin Cancer.

    Actas dermo-sifiliograficas·2024
    Same journal

    "Highlights from JAAD International: Noninvasive imaging for basal cell carcinoma".

    Journal of the American Academy of Dermatology·2026
    Same journal

    Effect of Primary Prophylaxis for Pneumocystis Pneumonia in Patients on Rituximab for Immune-Mediated Dermatologic Conditions: A Systematic Review and Meta-Analysis.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Real-World Effectiveness and Safety of Ritlecitinib in Adolescents with Severe Alopecia Areata: A 36-Week Single-Center Study.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Liquid Biopsy in Cutaneous Oncology: Current Practice and Future Directions.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Ethically protecting immunosuppressed patients in shared dermatology spaces.

    Journal of the American Academy of Dermatology·2026
    See all related articles

    This study reports a rare case of primary cutaneous lymphoplasmacytic lymphoma. The lymphoma uniquely produced IgG lambda immunoglobulin chains, with significant T cell and Langerhans cell involvement.

    Area of Science:

    • Dermatology
    • Hematology
    • Immunology

    Background:

    • Primary cutaneous lymphoplasmacytic lymphoma is a rare B-cell neoplasm.
    • Understanding its immunophenotype is crucial for diagnosis and treatment.

    Observation:

    • A case presented with a unique immunoglobulin synthesis pattern.
    • Immunohistochemical analysis utilized antihuman immunoglobulin antisera and T cell monoclonal antibodies.

    Findings:

    • The lymphoma cells synthesized immunoglobulin G (IgG) lambda light chains.
    • An important population of accessory cells, including T cells and Langerhans cells, was identified.

    Implications:

    • This case expands the known spectrum of immunoglobulin production in cutaneous lymphomas.

    Related Experiment Videos

  • The presence of accessory cells may influence the tumor microenvironment and disease progression.